MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Neuroprotective Potency of Tetrahydroisoquinoline a Novel Ayurveda Molecule in Experimental Parkinson’s Disease

    R. Banerjee, D. Nthenge-Ngumbau, R. Singh, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

    Objective: Tetrahydroisoquinoline (TIQ) an identified alkaloid from ancient Indian ‘Ayurveda’ medicine for Parkinson’s disease (PD) was tested for neuroprotection in a cellular system and a…
  • 2017 International Congress

    Evaluation of Swallowing Function in Parkinson’s Disease Patients with and without Dysphagia Complaints

    E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, A. Cakci, B. Gonenli, Y. Eren (Ankara, Turkey)

    Objective: To assess swallowing functions of symptomatic and asymptomatic patients Parkinson's disease (PD). Background: Swallowing studies in PD without dysphagia symptoms are lacking and swallowing…
  • 2017 International Congress

    WILSON’S DISEASE: A Mongolian case

    U. Dashdorj, S. Jambal (Ulaanbaatar 51, Mongolia)

    Objective: Objective: To determine the early clinical features that predict younger people who has Wilson’s disease(WD). Background: Backround: WD is fatal neurodegenerative  disorder that is…
  • 2017 International Congress

    Efficacy of Smartphone-enabled Active Tests in Automated PD Severity Assessment

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To compare the efficacy of five smartphone-enabled active tests in detecting severity changes after medication, via an automated Parkinson Disease Severity Score (PDSS). Background:…
  • 2017 International Congress

    Exercise Trends Reported in Parkinson’s Patients

    P. Raje, C. Branson, M.P. de Leon, M. Saint-Hilaire, A. Hohler, S. Ning (Boston, MA, USA)

    Objective: To examine trends in type, frequency, and effectiveness of exercise in Parkinson’s patients based on gender, race, and years since diagnosis. Background: Exercise has…
  • 2017 International Congress

    FDG PET studies in the differential diagnose of atypical parkinsonism and dementia syndromes.

    M.C. Peralta, M. Tourreilles, D. Menna, P. Perez Leguizamon, F. Taragano, M. Bastianello (Buenos Aires, Argentina)

    Objective: To describe the fluorodeoxyglucose (FDG) metabolic pattern and clinical features in patients with clinical diagnose of atypical parkinsonism such as Progressive Supranuclear Palsy (PSP),…
  • 2017 International Congress

    The association between motor laterality and cognitive impairment in Parkinson’s disease

    J.S. Kim, J.W. Cho, J. Youn (Seoul, Republic of Korea)

    Objective: Our study aimed to compare the cognitive function depending on the one-sided symptom dominance for investigating association between specific cognitive function and asymmetric motor…
  • 2017 International Congress

    Stabile cognitive profile one year after subthalamic nucleus deep brain stimulation in patients with advanced Parkinson’s disease

    T. Remšak, A. Bujisić, S. Šešok, S. Brezovar, A. Pražnikar, M. Kramberger, D. Georgiev, D. Flisar, K. Boetzel, J. Mehrkens, M. Benedičič, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To prospectively study the cognitive functions in Parkinson’s disease (PD) patients treated with deep brain stimulation of subthalamic nucleus (STN DBS). Background: STN DBS is a…
  • 2017 International Congress

    How common are the genomic rearrangements among possibly autosomal recessive PD cases in Turkey?

    G. Yalcin Cakmakli, A. Yuzbasioglu, G. Onal, B. Peynircioglu, M. Ozguc, S. Dokmeci (Emre), B. Elibol (Ankara, Turkey)

    Objective: In this study, we aimed to investigate the frequency and phenotypical features in a subset of early-onset Parkinson’s disease (EO-PD) (age-at-onset ≤45 years) patients due…
  • 2017 International Congress

    Alterations in lipid metabolism modify GBA1-mediated neurodegeneration in a Drosophila model of Parkinson’s disease

    M. Davis, R. Thomas, A. Germanos, S. Yu, B. Whitley, L. Pallanck (Seattle, WA, USA)

    Objective: To understand how glucocerebrosidase (GBA1) mutations increase susceptibility to Parkinson's disease (PD). Background: Our understanding of the pathogenesis PD remains limited, and currently no…
  • « Previous Page
  • 1
  • …
  • 275
  • 276
  • 277
  • 278
  • 279
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley